StockData

Align Technology vs Smith & Nephew

ALGN and SNN side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALGN and SNN compare

Smith & Nephew grew revenue faster over the last twelve months (6.1% versus 4.4% for Align Technology).

Align Technology scores higher on the StockData Score (13 against 6 for Smith & Nephew), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALGNSNN
Size and price
Market cap$11.6B–
Share price$163.46$30.51
Change, 1 year19.2%−6.7%
Change, 5 years−74.2%−7.1%
Beta (5Y)0.890.11
Employees20K18K
StockData Score
Total score13 (better)6
Valuation score4 (better)0
Growth score01 (better)
Performance score3 (better)1
Health score6 (better)4
Dividend score00
Valuation
P/E28.4×–
P/S2.8×–
P/B2.7×–
EV/EBITDA13.1×–
P/FCF18.3×–
PEG4.05–
FCF yield5.5%–
Fair value$184.79–
Margin of safety11.5%–
Growth
Revenue growth (TTM)4.4%6.1% (better)
Revenue growth, 5Y average10.3% (better)6.2%
Net income growth (TTM)−5.5%–
EPS growth (TTM)−3.0%52.3% (better)
EPS growth, 5Y average−24.1%6.9% (better)
Profitability
Gross margin68.0% (better)68.0%
Operating margin13.2% (better)12.9%
Net margin10.0%–
FCF margin15.3%–
Return on equity10.2%–
Return on invested capital13.0%13.0% (better)
Financial health
Debt / equity0.000.10 (better)
Net debt / EBITDA–−0.31
Interest coverage–5.7×
Current ratio1.402.14 (better)
Altman Z-score4.82–
Piotroski F-score6–
Dividends and buybacks
Buyback yield2.1%–
Shareholder yield2.1%–
Ownership
Held by institutions103%4.2%
Held by insiders2.3%25.1%
Insider net buying, 12 months−$1.5M–
Superinvestors holding1–
Short interest, % of float5.9%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.